
Inari Medical NARI
Quarterly report 2024-Q3
added 10-28-2024
Inari Medical Interest Expense 2011-2025 | NARI
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Inari Medical
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 294 K | 295 K | 1.14 M | 920 K | 887 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.14 M | 294 K | 706 K |
Quarterly Interest Expense Inari Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -130 K | 23 K | 78 K | - | -682 K | 26 K | 40 K | - | 74 K | 73 K | 73 K | - | 73 K | 74 K | 73 K | - | 251 K | 463 K | 346 K | - | 226 K | 229 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 463 K | -682 K | 77.1 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
-2.79 M | $ 10.27 | -1.25 % | $ 1.37 B | ||
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.81 | -1.3 % | $ 132 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 304.24 | -1.26 % | $ 8.58 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 45.22 | 0.2 % | $ 6.74 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 128.77 | 2.63 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 91.99 | -0.63 % | $ 135 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.08 | 6.94 % | $ 115 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.69 | -1.77 % | $ 696 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 164.09 | -0.81 % | $ 12.3 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.61 | 0.39 % | $ 1.22 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 1.06 | -0.47 % | $ 109 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.7 | -0.06 % | $ 343 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.81 | 0.41 % | $ 97.1 M | ||
|
AxoGen
AXGN
|
-199 K | $ 29.91 | -1.58 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.19 | -1.56 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.74 | 0.8 % | $ 409 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 86.2 | -0.57 % | $ 11.7 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 13.57 | 1.12 % | $ 1.05 B | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 20.02 | 0.28 % | $ 2.86 B | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.86 | 0.18 % | $ 3.41 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.6 | 0.78 % | $ 134 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 3.22 | -5.29 % | $ 5.03 M |